After more than a decade of ownership, Nordic Capital agrees £2.25bn Binding Site sale to Thermo Fisher

A Nordic Capital-led investor group has agreed the £2.25bn sale of medical diagnostics business The Binding Site Group to Thermo Fisher Scientific.